Get the Stockscreener App
1.12
5.08%
-0.06
After Hours:
1.12
Jupiter Neurosciences Inc stock is traded at $1.12, with a volume of 41,514.
It is down -5.08% in the last 24 hours and down -18.84% over the past month.
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
See More
Previous Close:
$1.18
Open:
$1.2
24h Volume:
41,514
Relative Volume:
0.35
Market Cap:
$38.56M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-12.70
EPS:
-0.0882
Net Cash Flow:
-
1W Performance:
-1.75%
1M Performance:
-18.84%
6M Performance:
+0.00%
1Y Performance:
-92.71%
1-Day Range:
$1.10
$1.2299
1-Week Range:
$1.10
$1.29
52-Week Range:
$0.51
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Name
Jupiter Neurosciences Inc
Sector
Industry
Phone
(561) 406-6154
Address
1001 NORTH US HWY 1, JUPITER
Compare JUNS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.12 | 40.62M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jupiter Neurosciences Inc Stock (JUNS) Latest News
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq - Yahoo Finance
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum - Yahoo Finance
Why Jupiter Neurosciences Inc. stock attracts global investorsWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Published on: 2025-11-27 23:20:01 - moha.gov.vn
Jupiter Neurosciences files rospectus related to resale of up to 10 million shares of our common stock by selling stockholder - marketscreener.com
Jupiter Neurosciences Inc Stock Analysis and ForecastPortfolio Diversification Tips & Watch Expert Picks Before They Rally - earlytimes.in
How Jupiter Neurosciences Inc. stock reacts to global recession fearsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Will Jupiter Neurosciences Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
How Jupiter Neurosciences Inc. stock benefits from strong dollar2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Is Jupiter Neurosciences Inc. stock overvalued by current metricsIndex Update & Weekly Breakout Stock Alerts - newser.com
A activity2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Why hedge funds are buying Jupiter Neurosciences Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Is Jupiter Neurosciences Inc. stock safe for conservative investorsProfit Target & Consistent Return Investment Signals - newser.com
Will Jupiter Neurosciences Inc. stock continue dividend increasesJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
Sentiment analysis tools applied to Jupiter Neurosciences Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
What insider trading reveals about Jupiter Neurosciences Inc. stockWeekly Profit Report & Smart Money Movement Tracker - newser.com
Does Jupiter Neurosciences Inc. fit your quant trading modelWeekly Profit Report & AI Based Buy and Sell Signals - newser.com
Will Jupiter Neurosciences Inc. stock keep outperforming rivalsWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Jupiter Neurosciences Inc. stock is a value investor pickTake Profit & Fast Entry High Yield Tips - newser.com
Why Jupiter Neurosciences Inc. stock could be next big winnerIPO Watch & Safe Capital Growth Trade Ideas - newser.com
Can you recover from losses in Jupiter Neurosciences Inc.2025 Stock Rankings & High Yield Equity Trading Tips - newser.com
Jupiter Neurosciences Inc Stock (JUNS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):